Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 57% ± 19% | |
peripheral blood | 13 studies | 24% ± 8% | |
lung | 11 studies | 34% ± 15% | |
eye | 8 studies | 46% ± 25% | |
heart | 5 studies | 40% ± 13% | |
kidney | 5 studies | 34% ± 15% | |
liver | 4 studies | 40% ± 15% | |
adipose | 4 studies | 44% ± 16% | |
bone marrow | 3 studies | 30% ± 18% | |
intestine | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6893.96 | 1445 / 1445 | 100% | 21.32 | 183 / 183 |
brain | 100% | 5780.37 | 2636 / 2642 | 100% | 25.45 | 702 / 705 |
breast | 100% | 7462.38 | 459 / 459 | 99% | 23.64 | 1109 / 1118 |
lung | 100% | 7393.99 | 578 / 578 | 99% | 15.88 | 1143 / 1155 |
thymus | 100% | 8508.49 | 653 / 653 | 99% | 18.68 | 598 / 605 |
ovary | 100% | 8372.08 | 180 / 180 | 99% | 15.42 | 425 / 430 |
prostate | 100% | 5582.94 | 245 / 245 | 99% | 17.82 | 496 / 502 |
intestine | 100% | 6970.91 | 966 / 966 | 98% | 12.97 | 516 / 527 |
pancreas | 100% | 5446.12 | 328 / 328 | 98% | 12.85 | 174 / 178 |
stomach | 100% | 6266.65 | 359 / 359 | 98% | 15.83 | 279 / 286 |
kidney | 100% | 3667.01 | 89 / 89 | 97% | 13.76 | 878 / 901 |
adrenal gland | 100% | 5757.72 | 258 / 258 | 97% | 12.01 | 224 / 230 |
bladder | 100% | 6231.24 | 21 / 21 | 97% | 11.48 | 489 / 504 |
skin | 100% | 8233.82 | 1809 / 1809 | 97% | 12.74 | 456 / 472 |
uterus | 100% | 8184.40 | 170 / 170 | 95% | 11.53 | 437 / 459 |
liver | 100% | 2734.55 | 226 / 226 | 75% | 5.50 | 305 / 406 |
adipose | 100% | 6737.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7119.88 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 8375.25 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6186.66 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.03 | 1 / 1 |
heart | 96% | 3623.77 | 824 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 11.47 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 86% | 7.02 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 83% | 8.54 | 24 / 29 |
peripheral blood | 81% | 4364.96 | 752 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032259 | Biological process | methylation |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0006338 | Biological process | chromatin remodeling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035097 | Cellular component | histone methyltransferase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0044666 | Cellular component | MLL3/4 complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042800 | Molecular function | histone H3K4 methyltransferase activity |
GO_0016746 | Molecular function | acyltransferase activity |
GO_0042054 | Molecular function | histone methyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0140999 | Molecular function | histone H3K4 trimethyltransferase activity |
GO_0140945 | Molecular function | histone H3K4 monomethyltransferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KMT2C |
Protein name | Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) Lysine methyltransferase 2C [histone H3]-lysine(4) N-methyltransferase (EC 2.1.1.364) |
Synonyms | KIAA1506 HALR MLL3 |
Description | FUNCTION: Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) . Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place . Likely plays a redundant role with KMT2D in enriching H3K4me1 mark on primed and active enhancer elements . . |
Accessions | H7C2V8 ENST00000262189.11 [Q8NEZ4-1] A0A804HKQ3 A0A804HJT1 H7BY37 ENST00000684550.1 H0YNL4 A0A804HJV8 A0A804HJU5 ENST00000682283.1 [Q8NEZ4-3] ENST00000683670.1 ENST00000679645.1 ENST00000360104.8 A0A804HLD4 A0A804HIS4 A0A804HJ77 A0A804HJ27 ENST00000682176.1 ENST00000680039.1 A0A7P0TBM6 ENST00000681082.1 A0A7P0TAQ8 ENST00000683502.1 ENST00000683178.1 ENST00000418061.2 ENST00000680029.1 ENST00000418673.2 A0A804HKW4 ENST00000684307.1 A0A7P0Z448 ENST00000679560.1 ENST00000683616.1 A0A7P0T9K8 ENST00000683625.1 ENST00000683200.1 ENST00000424877.6 ENST00000684140.1 A0A7P0T9U9 A0A7P0T8F0 A0A7P0T9N3 A0A804HI08 A0A7P0T9Q7 A0A804HIW6 ENST00000684398.1 ENST00000679882.1 A0A804HLA5 A0A7P0TA60 A0A804HKJ1 H0Y765 ENST00000681838.1 ENST00000684069.1 C9J4Z5 ENST00000681033.1 ENST00000452749.2 A0A804HIK3 H7C212 A0A7P0TAI3 ENST00000680877.1 ENST00000683490.1 A0A804HK48 A0A804HIM6 ENST00000558665.2 ENST00000684649.1 ENST00000683397.1 A0A804HIF3 ENST00000682916.1 ENST00000684262.1 Q8NEZ4 ENST00000682040.1 A0A804HIM1 ENST00000682301.1 ENST00000684278.1 A0A804HIG3 A0A804HHW0 ENST00000683159.1 ENST00000684261.1 A0A804HJR9 ENST00000680969.1 A0A804HKS3 |